Patent · US Active

Class of HDAC inhibitors expands the renal progenitor cells population and improves the rate of recovery from acute kidney injury

US10626071B2 · kind B2 · utility

0Cited by

2References

12Claims

0Family size

Assignee

University of Pittsburgh—Of the Commonwealth System of Higher Education · US

Inventors

Billy W. Day · Pittsburgh, US
Neil Hukriede · Washington, US

Key dates

Filing date	Apr 24, 2018
Grant date	Apr 21, 2020
Priority date	—
Expiry date	Apr 24, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C323/62
WIPO fieldChemical engineering
WIPO sectorChemistry

Abstract

Compounds and compositions are provided that inhibit histone deacylase activity and which expand renal progenitor cell populations and improve kidney function in a damaged kidney. Methods of use of the compounds and compositions are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.